1. Home
  2. NOMA vs HBIO Comparison

NOMA vs HBIO Comparison

Compare NOMA & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOMADAR Corp.

NOMA

NOMADAR Corp.

N/A

Current Price

$1.16

Market Cap

30.2M

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

N/A

Current Price

$9.23

Market Cap

26.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NOMA
HBIO
Founded
2023
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
30.2M
26.5M
IPO Year
2025
2000

Fundamental Metrics

Financial Performance
Metric
NOMA
HBIO
Price
$1.16
$9.23
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $10.25
AVG Volume (30 Days)
10.9K
★ 17.8K
Earning Date
11-23-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$6,376.00
★ $116,176,000.00
Revenue This Year
N/A
$3.75
Revenue Next Year
N/A
$5.46
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.11
$0.40
52 Week High
$10.00
$9.32

Technical Indicators

Market Signals
Indicator
NOMA
HBIO
Relative Strength Index (RSI) 30.84 67.38
Support Level N/A $5.91
Resistance Level $1.88 N/A
Average True Range (ATR) 0.18 0.43
MACD -0.05 0.04
Stochastic Oscillator 7.93 76.67

Price Performance

Historical Comparison
NOMA
HBIO

About NOMA NOMADAR Corp.

Nomadar Corp operates at the intersection of sports and technology, focusing on high-performance training programs and cultural exchange. The company aims to connect athletes, coaches, and fans through inventive technological solutions, enhancing sports development beyond physical borders. It offers services like the High Performance Training (HPT) program and promotes the legacy of iconic athletes. The Company generates revenue through its High Performance Training Program and events management at the JP Financial Stadium.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: